Trade Summary

1 week ago, Wilson Martin, serving as GC at Rocket Pharmaceuticals, Inc. (RCKT), sold 12,253 shares at $3.31 per share, for a total transaction value of $40,582.00. Following this transaction, Wilson Martin now holds 683,376 shares of RCKT.

This sale represents a 2.00% decrease in Wilson Martin's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, February 13, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, 5 days after the trade was made.

Rocket Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.